1. The Defendant shall pay to the Plaintiff KRW 30,00,000 and the interest rate of KRW 15% per annum from February 25, 2016 to the day of complete payment.

(b) there is a small brutal disease on the left-hand side and in the forward radiation pipeline;

On December 11, 2015, “The medical doctor C of the above hospital was diagnosed with MOI’s opinion. On December 11, 2015, on the basis of the above MO’s opinion, the medical doctor C of the above hospital diagnosed “I69.319 (I63.9) of Madro-si (H53.2), Madro-Madro (I69.319) of Madro-Madro (I63.9) of Madro-Madro-Madro(I63.3) of Madro-Madro(I63.6) of Madro-Madro(I64) of Madro(I68) of Madro-Madro(I64) of Madro(I68) of Madro-Madro(I68) of Madro(Korean Standard Disease Classification) of Madro-Madro(Madro) of Madro(G).368).”

[Ground of recognition] Facts without dispute, Gap evidence Nos. 1 through 4, 8, 9 (including each number; hereinafter the same shall apply), Eul evidence Nos. 4 and 6, the purport of the whole pleadings

2. The assertion and judgment

A. The plaintiff asserted that the contract of this case was diagnosed by a doctor on the basis of MFI test as stipulated in the terms and conditions of the insurance contract of this case, and that the contract of this case does not distinguish between urgency and chronicity. Thus, the defendant cannot refuse payment of insurance proceeds from MF test on the ground that MF test was not discovered.

In this regard, the defendant provided that the diagnosis fund of the insurance contract of this case shall be paid, and there is an opinion of nephical ideal due to disease caused by the reduction or suspension of cerebral blood.